Related by context. All words. (Click for frequent words.) 75 Fludara 72 FOLFIRI 71 chlorambucil 71 FOLFOX 70 erlotinib Tarceva ® 70 Fludarabine 70 docetaxel chemotherapy 70 dacarbazine 70 azacitidine 69 low dose cytarabine 69 Doxil ® 69 dasatinib Sprycel ® 69 Peg IFN 69 bendamustine 69 sorafenib Nexavar 69 mycophenolate mofetil 69 XELOX 69 DMARDs 68 cetuximab Erbitux R 68 pegylated liposomal doxorubicin 68 docetaxel 68 dasatinib 68 irinotecan 68 ribavirin RBV 68 CHOP chemotherapy 68 sunitinib 68 vinorelbine 68 carboplatin paclitaxel 67 imatinib Gleevec ® 67 rituximab 67 5FU 67 pegylated interferon alfa 2a 67 Pegasys ® 67 fluorouracil 67 leukemia CLL 67 cetuximab Erbitux ® 67 metastatic renal cell carcinoma 67 docetaxel Taxotere 67 Irinotecan 67 pegylated interferon alfa 67 Taxotere ® 67 bicalutamide 67 FOLFOX4 67 bevacizumab Avastin ® 67 adriamycin 66 3TC lamivudine Epivir 66 ritonavir boosted 66 trabectedin 66 5-FU/LV 66 interferon alfa 66 vandetanib 66 pegylated interferon alpha 66 oblimersen 66 trastuzumab 66 standard chemotherapy regimen 66 DMARDS 66 idarubicin 66 dose cytarabine 66 ribavirin therapy 66 temsirolimus 66 temozolomide 66 gemcitabine chemotherapy 66 standard chemotherapy regimens 66 irinotecan containing 66 HER2 positive metastatic breast 66 oxaliplatin 66 doxorubicin HCl liposome injection 66 infusional 5-FU/LV 66 cetuximab 66 gemcitabine carboplatin 66 DOXIL 66 anthracyclines taxanes 66 mitoxantrone 66 Lenalidomide 66 alfa 2a 66 cytotoxic chemotherapy 65 mRCC 65 mapatumumab 65 nilotinib 65 MabCampath 65 Capecitabine 65 sorafenib Nexavar ® 65 alpha 2b 65 imatinib 65 relapsed refractory 65 alkylating agent 65 bevacizumab Avastin 65 imatinib Gleevec 65 bortezomib 65 Bevacizumab 65 anthracycline taxane 65 trastuzumab Herceptin R 65 Herceptin trastuzumab 65 TNF inhibitor 65 bevacizumab 65 5 fluorouracil 65 AVASTIN 65 fluoropyrimidine 65 liposomal doxorubicin 65 Torisel 65 interferon alfa 2a 65 cytarabine 65 5 FU leucovorin 65 capecitabine 65 interferon alfa 2b 65 alkylating agents 65 Pemetrexed 65 disease modifying antirheumatic 65 Navelbine ® 65 daunorubicin 65 peginterferon 65 unresectable 65 PREZISTA r 65 leucovorin 65 dexamethasone Decadron 65 gemcitabine Gemzar 65 PegIFN RBV 65 sorafenib 65 posaconazole 65 hypomethylating agents 65 chronic lymphocytic leukemia CLL 65 bevacizumab Avastin R 64 Fludara ® 64 telaprevir dosed 64 azathioprine 64 imatinib resistant 64 voriconazole 64 pemetrexed 64 plus prednisone 64 TKI therapy 64 Camptosar ® 64 plus dexamethasone 64 chemotherapy regimens 64 low dose dexamethasone 64 docetaxel Taxotere ® 64 pertuzumab 64 lenalidomide 64 pegylated interferon 64 taxane therapy 64 erlotinib 64 lamivudine 64 Paraplatin ® 64 heavily pretreated patients 64 efavirenz EFV 64 fulvestrant 64 trastuzumab Herceptin ® 64 DOXIL ® 64 oral vancomycin 64 gemcitabine 64 Gemcitabine 64 6 mercaptopurine 64 Erlotinib 64 irbesartan 64 amphotericin B 64 FluCAM 64 interferon therapy 64 Doxil 64 achieve sustained virologic 64 relapsed ovarian cancer 64 PegIntron 64 lopinavir r 64 mCRC patients 64 plus ribavirin 63 peginterferon alfa 2a Pegasys 63 PEGINTRON TM 63 sunitinib Sutent ® 63 lenalidomide Revlimid R 63 cyclophosphamide 63 dacarbazine DTIC 63 Peginterferon alfa 2b 63 melphalan prednisone 63 Hycamtin 63 imipenem 63 refractory chronic lymphocytic 63 receptor tyrosine kinase inhibitor 63 DMARD therapy 63 decitabine 63 palifermin 63 protease inhibitor PI 63 chemoradiation 63 methotrexate MTX 63 dasatinib Sprycel 63 pomalidomide 63 Peginterferon 63 CANCIDAS 63 DMARD 63 fluconazole 63 adalimumab Humira 63 TNF inhibitors 63 sunitinib malate 63 paclitaxel Taxol 63 AZT zidovudine Retrovir 63 trastuzumab Herceptin 63 estramustine 63 Peginterferon Alfa 2a 63 methotrexate 63 Pegylated interferon 63 indolent NHL 63 cabazitaxel 63 Vectibix 63 metastatic RCC 63 Dasatinib 63 tocilizumab 63 dexamethasone 63 MGd 63 TKIs 63 topotecan 63 TORISEL 63 cisplatin 63 plus prednisone prednisolone 63 taxane chemotherapy 63 superficial bladder cancer 63 lapatinib 63 abatacept Orencia 63 FOLFIRI alone 63 Epivir 63 Noxafil 63 Cyclophosphamide 63 B CLL 63 metastatic castration resistant 63 Ribavirin 63 TNF antagonists 63 anthracycline containing 63 flutamide 62 chemotherapy regimen 62 Gemzar ® 62 boosted protease inhibitor 62 sulphonylurea 62 Navelbine 62 PegIFN 62 5 FU 62 sorafenib Nexavar R 62 alpha 2a 62 tyrosine kinase inhibitor 62 Rituxan rituximab 62 imatinib mesylate 62 docetaxel Taxotere R 62 efalizumab 62 Mitoxantrone 62 cisplatin chemotherapy 62 bleomycin 62 clopidogrel Plavix 62 thymalfasin 62 nilotinib Tasigna ® 62 etoposide 62 refractory chronic myeloid 62 APTIVUS r 62 neoadjuvant chemotherapy 62 biologic therapy 62 ZOLINZA 62 pegylated interferon alfa 2b 62 infliximab monotherapy 62 imatinib therapy 62 Taxotere chemotherapy 62 TACE 62 Rituximab 62 metastatic hormone refractory 62 Cisplatin 62 peginterferon alfa 2b 62 irinotecan doxorubicin oxaliplatin paclitaxel 62 adalimumab 62 PEG IFN 62 refractory multiple myeloma 62 Elitek 62 carboplatin 62 anti TNF 62 FOLFOX6 62 stage IIIb IV 62 Camptosar 62 Cytoxan 62 epirubicin 62 meropenem 62 fluticasone salmeterol 62 tigecycline 62 pegylated interferons 62 NRTIs 62 Flu Cy 62 thalidomide Thalomid 62 K ras mutations 62 partial remissions 62 mitoxantrone chemotherapy 62 situ CIS 62 HCV genotype 1 62 peginterferon alfa 2a 62 weekly subcutaneous injections 62 tenofovir emtricitabine 62 peginterferon alfa 62 alefacept 62 TNF antagonist 62 cyclophosphamide methotrexate 62 Copegus 62 capecitabine Xeloda 62 amoxicillin clavulanate 62 dose dexamethasone 62 relapsed refractory multiple myeloma 62 galiximab 62 Traficet EN 62 bortezomib Velcade R 62 stage IIIB 62 FUSILEV enhances 62 Roche Pegasys 62 pegylated alpha interferon 62 Xeloda ® 62 Bortezomib 62 BEACOPP 62 iniparib 62 Amrubicin 62 metastatic colorectal cancer 62 subcutaneously administered 61 Jevtana 61 refractory CLL 61 monotherapy 61 peg IFN 61 alpha interferons 61 Azacitidine 61 refractory AML 61 5 Fluorouracil 61 Pharmacokinetics PK 61 ritonavir boosted atazanavir 61 relapsed SCLC 61 levofloxacin 61 saline placebo 61 chemotherapeutic regimens 61 CAELYX 61 cytotoxic therapy 61 INVANZ 61 dose regimens 61 primary hypercholesterolemia 61 Taxotere R 61 sorafenib tablets 61 adverse cytogenetics 61 relapsed MM 61 anti rheumatic 61 Trastuzumab 61 lapatinib Tykerb 61 anthracyclines 61 relapsed CLL 61 placebo dexamethasone 61 cell lymphoma CTCL 61 SUTENT 61 PEGylated Fab fragment 61 Epivir HBV 61 piperacillin tazobactam 61 fluvastatin 61 Tasigna nilotinib 61 bortezomib Velcade 61 Topotecan 61 hepatic metastases 61 Platinol 61 gemcitabine cisplatin 61 biologic DMARD 61 mycophenolate mofetil MMF 61 darunavir ritonavir 61 prostate cancer HRPC 61 nucleoside reverse transcriptase inhibitor 61 Copegus ribavirin 61 Taxotere 61 Pegylated Interferon 61 cidofovir 61 Folfox 61 panitumumab Vectibix 61 Lamivudine 61 raltegravir 61 advanced NSCLC 61 metastatic malignant 61 Taxotere docetaxel 61 FOLPI 61 HBeAg positive patients 61 gastrointestinal stromal tumors 61 INTELENCE 61 pharmacologically active isomer 61 enfuvirtide 61 Pegintron 61 antithymocyte globulin 61 trimethoprim sulfamethoxazole 61 gastrointestinal stromal tumors GIST 61 pyrazinamide 61 oral clodronate 61 micafungin 61 pimozide 61 interferon alpha 61 Aflibercept 61 metastatic HRPC 61 paclitaxel cisplatin 61 PREZISTA rtv 61 ritonavir boosted lopinavir 61 amrubicin 61 Tipranavir 61 amprenavir 61 Xelox 61 leukemia AML 61 temsirolimus Torisel ® 61 Carboplatin 61 irinotecan chemotherapy 61 Mylotarg 61 erlotinib Tarceva R 61 gastrointestinal stromal tumor GIST 61 Rebetol 61 tenofovir Viread 60 preoperative chemotherapy 60 neoadjuvant 60 prior chemotherapy regimens 60 recurrent glioblastoma multiforme 60 pegylated interferon peg IFN 60 tenofovir DF 60 abatacept 60 Aptivus ® 60 mTOR inhibitor 60 TYKERB 60 doxorubicin cyclophosphamide 60 monotherapies 60 saquinavir ritonavir 60 eplerenone 60 overlapping toxicities 60 Hycamtin ® 60 Interferon alfa 60 FOLFOX4 alone 60 FOLFOX chemotherapy 60 etanercept Enbrel 60 DAPT 60 oxaliplatin Eloxatin 60 interferon IFN 60 PEGylated anti 60 entecavir 60 tinidazole 60 EGFR antibodies 60 immunosuppressant 60 everolimus tablets 60 tyrosine kinase inhibitors 60 PEGINTRON 60 abiraterone acetate 60 REVLIMID ® 60 PEG interferon 60 temozolomide TMZ 60 Infliximab 60 mitomycin 60 refractory NSCLC 60 ethambutol 60 GW# [003] 60 anakinra 60 Tarceva erlotinib 60 mg qd 60 stavudine d4T 60 gefitinib Iressa 60 TAXOTERE R 60 clodronate 60 infliximab 60 viral kinetics 60 SPRYCEL ® 60 Genasense 60 temsirolimus Torisel 60 dosage regimens 60 Ph + ALL 60 gefitinib 60 T#I mutation 60 vorinostat 60 Xeloda capecitabine 60 peginterferon alpha 2a 60 linezolid 60 Paraplatin ® carboplatin 60 Vidaza ® 60 administered concomitantly 60 ganciclovir 60 Eli Lilly Gemzar 60 interferon 60 vinca alkaloids 60 arsenic trioxide 60 gadobutrol 60 Targretin 60 Zolinza 60 RoACTEMRA 60 metastatic GIST 60 recurrent GBM 60 IFN beta 60 intravenously administered 60 hematologic toxicity 60 Ranolazine 60 basiliximab 60 KRAS mutant tumors 60 taxanes 60 rizatriptan 60 xanthine oxidase inhibitor 60 FEMALES SHOULD BE ADVISED 60 cyclophosphamide doxorubicin vincristine 60 prednisone prednisolone 60 ABVD 60 mg kg dose 60 tyrosine kinase inhibitor TKI 60 Fulvestrant 60 paclitaxel Taxol ® 60 YONDELIS 60 ceftriaxone 60 Platinol ® 60 citalopram 60 PEGASYS ® 60 Velcade bortezomib 60 remission induction 60 eribulin 60 Cloretazine 60 follicular NHL 60 locoregional 60 4mg/kg 60 receiving prophylactic anticoagulation 60 squamous histology 60 amodiaquine 60 fluticasone 60 Anti TNF 60 metastatic CRC 60 chemoradiation therapy 60 follicular lymphoma FL 60 pamidronate 60 drug DMARD 60 interferon gamma 1b 60 fluorouracil leucovorin 60 paclitaxel carboplatin 60 enalapril 60 systemic corticosteroids 60 OADs 60 doxorubicin 60 uric acid lowering 60 Alemtuzumab 60 metastatic malignant melanoma 60 goserelin 60 MyVax R 60 tyrosine kinase inhibitors TKIs 60 Nexavar sorafenib 60 APTIVUS 60 epoetin alfa 60 protease inhibitors PIs 60 isoproterenol 60 HBeAg negative patients 60 paroxetine Paxil 60 glatiramer acetate 60 calcineurin inhibitors 60 nilotinib Tasigna 60 TELCYTA 59 TNF Tumor Necrosis Factor 59 5 FU capecitabine 59 5 fluorouracil leucovorin 59 Pegasys peginterferon alfa 2a 59 myelodysplastic myeloproliferative diseases 59 DLBCL 59 nevirapine Viramune 59 Torisel temsirolimus 59 trans retinoic acid 59 platelet inhibitor 59 rituximab Rituxan ® 59 anthracycline 59 CsA 59 conventional DMARDs 59 lenalidomide dexamethasone 59 TEMODAL 59 panitumumab 59 azacytidine 59 lamivudine 3TC 59 interferon beta 1a 59 Hodgkin lymphoma NHL 59 paricalcitol 59 KRAS wild 59 romiplostim 59 levosimendan 59 Platinol ® cisplatin 59 EGFR expressing mCRC 59 dose cohorts 59 Tarceva TM 59 abacavir lamivudine 59 risperidone Risperdal 59 VPRIV 59 cyclophosphamide chemotherapy 59 fludarabine cyclophosphamide 59 MAGE A3 ASCI 59 Taxol ® 59 hydroxymethyl coenzyme 59 doxazosin 59 potent CYP#A# inhibitors 59 heavily pretreated 59 LEXIVA r 59 untreated multiple myeloma 59 Melphalan 59 FOLFOX regimen 59 chronic plaque psoriasis 59 metformin HCl 59 tipranavir 59 PEG Intron 59 titrated glipizide 59 pegylated 59 ara C 59 alpha interferon 59 ELOXATIN 59 ketoconazole 59 oral rivaroxaban 59 hypereosinophilic syndrome 59 #mg BID [003] 59 eribulin mesylate 59 Sorafenib 59 efavirenz Sustiva 59 Monotherapy 59 virologic failure 59 Epirubicin 59 nab paclitaxel 59 pegylated interferon alpha 2a 59 paclitaxel chemotherapy 59 Bevacizumab Avastin 59 tazobactam 59 NOXAFIL 59 cytarabine daunorubicin 59 adjuvant chemotherapy 59 pegfilgrastim 59 TMP SMX 59 ceftazidime 59 Certolizumab pegol 59 COMBIVIR 59 nelfinavir 59 OPAXIO 59 VIDAZA 59 oxcarbazepine 59 active comparator 59 adefovir dipivoxil 59 Sanofi Aventis Taxotere 59 zoledronic acid 59 atazanavir 59 darunavir 59 Darunavir 59 Gleevec imatinib 59 Taxol paclitaxel 59 benazepril 59 evaluating Xcytrin 59 Seliciclib 59 erlotinib Tarceva 59 rituximab Rituxan 59 Gefitinib 59 nucleoside analogues 59 GnRH agonists 59 Kit CD# positive 59 recurrent NSCLC 59 iodixanol 59 receiving VICTRELIS 59 infliximab Remicade 59 Nilotinib 59 pharmacokinetic interactions 59 cisplatin gemcitabine 59 mcg kg 59 LPV r 59 doxorubicin Adriamycin 59 COPEGUS 59 antiandrogen 59 TNF antagonist therapies 59 Sustiva efavirenz 59 HERCEPTIN 59 imatinib mesylate Gleevec 59 IFN alpha 59 potentially hepatotoxic 59 comparator arm 59 cyclophosphamide Cytoxan 59 Naive Patients 59 dalteparin 59 myelodysplastic syndrome MDS 59 EGFR inhibitors 59 chemoradiotherapy 59 idraparinux 59 Neoadjuvant 59 fenofibric acid 59 systemic ALCL 59 NNRTI 59 non metastatic osteosarcoma 59 chemotherapy docetaxel 59 Trizivir 59 zidovudine AZT 59 HCV genotypes 59 Alkeran 59 baminercept 59 Pfizer Sutent 59 8mg/kg 59 immunomodulatory therapy 59 mcg QD 59 Sprycel dasatinib 59 NRTI 59 infusional 59 CLL SLL 59 indinavir 59 nicardipine 59 ADP receptor antagonist 59 TMC# r 59 ibritumomab tiuxetan 59 oral antidiabetic 59 SCCHN 59 nucleoside analogs 59 mycophenolic acid 59 adefovir 59 capecitabine Xeloda R 59 plus COPEGUS 59 chronic myeloid leukemia CML 59 cinacalcet 59 Lapatinib 58 CIMZIA ™ 58 anti EGFR antibody 58 Copegus ® 58 curative resection 58 HCV RESPOND 2 58 folinic acid 58 ACTEMRA TM 58 purpura ITP 58 axitinib 58 chemotherapy FOLFOX 58 colorectal liver metastases 58 unresectable stage 58 Proleukin 58 Virologic 58 TO AVOID PREGNANCY WHILE 58 docetaxel prednisone 58 proteasome inhibitor 58 REVLIMID R 58 KRAS mutations 58 unfractionated heparin 58 leflunomide 58 caspofungin 58 beclomethasone dipropionate 58 ciclosporin 58 Temsirolimus 58 insulin glulisine 58 Vidaza 58 postoperative chemotherapy 58 antimetabolite 58 nucleoside analog 58 taxotere 58 ALK inhibitor 58 interferon ribavirin 58 Docetaxel 58 chemotherapeutic agent 58 evaluating tivozanib 58 allogeneic SCT 58 methotrexate monotherapy 58 Adalimumab 58 methotrexate therapy 58 letrozole Femara 58 Ixempra 58 FOLFOX6 chemotherapy regimen 58 HBeAg + 58 administered subcutaneously 58 cytotoxic agents 58 Romiplostim 58 Bezielle 58 panitumumab Vectibix R 58 Cladribine tablets 58 Filgrastim 58 ddI 58 Abatacept 58 Pertuzumab 58 Talabostat 58 Pegylated Liposomal Doxorubicin 58 DEB# 58 renal toxicity 58 atazanavir ritonavir 58 splenectomized patients 58 TREANDA 58 Halaven 58 advanced metastatic renal 58 HAART regimen 58 #mg/m# [001] 58 free survival PFS 58 pazopanib 58 EGFR tyrosine kinase inhibitors 58 echinocandin 58 Doxorubicin 58 mg QD 58 YERVOY 58 paclitaxel 58 Votrient 58 Bosutinib 58 Elotuzumab 58 stavudine 58 liposomal amphotericin B 58 NRTI backbone 58 G CSF 58 NSCLC 58 Revlimid lenalidomide 58 leukotriene receptor antagonist 58 Neulasta ® 58 omalizumab 58 Campath alemtuzumab 58 antiarrhythmic drug 58 adjuvant radiotherapy 58 previously untreated follicular 58 lumiliximab 58 chemotherapy cisplatin 58 clomipramine 58 Bacillus Calmette Guerin BCG 58 macrolide antibiotic 58 insulin detemir 58 mcg BID 58 beta 1a 58 low dose ritonavir 58 etanercept 58 doripenem 58 Imatinib 58 pimecrolimus 58 regorafenib 58 myeloablative 58 CHOP cyclophosphamide doxorubicin vincristine 58 Relapsed 58 small lymphocytic lymphoma 58 ® lenalidomide 58 zalutumumab 58 ULORIC 58 non metastatic resectable 58 #mg dose [001] 58 DFMO 58 HCV SPRINT 58 KRAS mutations occur 58 Fluconazole 58 Sandostatin 58 ZYVOX 58 resectable 58 Dabigatran etexilate 58 pancreatic neuroendocrine tumors 58 abciximab 58 VAPRISOL 58 immunosuppressive agents 58 HBeAg negative 58 PEGylated interferon beta 1a 58 aspirin clopidogrel 58 Boceprevir 58 Everolimus 58 Gemzar gemcitabine 58 Hypersensitivity reactions 58 HBeAg positive 58 mg/m2 administered 58 rituximab refractory 58 tenofovir disoproxil fumarate 58 Nexavar ® 58 Methotrexate 58 aspirin heparin 58 FASLODEX 58 placebo controlled clinical trials 58 vinca alkaloid 58 cutaneous T cell 58 Gleevec resistant 58 CIMZIA TM 58 irinotecan oxaliplatin 58 Clolar ® 58 virological failure 58 CYP#A# substrate 58 lamotrigine 58 IXEMPRA 58 taxane 58 HER2 negative 58 Leucovorin 58 EGFR tyrosine kinase inhibitor 58 epirubicin cyclophosphamide 58 Arranon 58 Temozolomide 58 SCIg 58 Cytarabine 58 metformin monotherapy 58 Gleevec imatinib mesylate 58 lopinavir 58 Xeloda 58 refractory ovarian cancer 58 COPEGUS R 58 EFAPROXYN 58 pegylated liposomal doxorubicin PLD 58 Vidaza R 58 rilonacept 58 octreotide 58 chemotherapies 58 BAY #-# 58 hypercalcemia 58 chlorthalidone 58 fallopian tube carcinoma 58 lymphoma CTCL 58 Vinorelbine 58 Bicalutamide 58 plus gemcitabine 58 anthracycline therapy 58 VFEND 58 Valcyte 58 BRAF inhibitor 58 achieved PASI 58 certolizumab 58 AGILECT R 58 gp# vaccine 58 Xcytrin 58 mitoxantrone plus 58 Myelodysplastic Syndrome MDS 58 tamoxifen Nolvadex 58 ARIMIDEX 58 paclitaxel Taxol R 58 oral allopurinol 58 Cetuximab 58 non squamous NSCLC 58 REVLIMID lenalidomide 58 deferoxamine 58 diuretic chlorthalidone 58 Carvedilol 58 peginterferon alfa 2a #KD 58 fluticasone propionate 58 typical antipsychotics 58 Soft Tissue Sarcoma 58 adjuvant tamoxifen 58 R lenalidomide 58 zoledronate 58 Vfend 58 Hydrochlorothiazide 58 EPIVIR 58 mutated KRAS 58 Peginterferon alfa 2a 58 natalizumab 58 salmeterol fluticasone 58 neoadjuvant therapy 58 febuxostat 57 Voreloxin 57 Tocilizumab 57 HGS ETR2 57 q#h 57 rifamycin 57 Eloxatin R 57 relapsing multiple sclerosis 57 adecatumumab 57 Campath 57 elotuzumab 57 visilizumab 57 T#I [002] 57 angiotensin converting enzyme inhibitors 57 subependymal giant cell 57 divalproex sodium 57 immunoconjugate 57 progressive psoriatic arthritis 57 Pixantrone 57 HMG CoA reductase inhibitors 57 BCG refractory 57 metformin sulfonylurea 57 bosentan 57 danazol 57 rHuEPO 57 Mg Usa 57 candesartan cilexetil 57 achieved ACR# 57 AMN# [001] 57 EGFR TKI 57 REMICADE ® 57 Cremophor 57 plus DOXIL 57 melphalan 57 ABC/3TC 57 Zorbtive TM 57 erythropoietic 57 GPIIb IIIa 57 antiandrogens 57 APTIVUS R 57 chronic hepatitis B. 57 chronic HCV genotype 57 tamoxifen therapy 57 intravenous bisphosphonates 57 patients evaluable 57 Pioglitazone 57 itraconazole 57 oral levofloxacin 57 somatostatin analogues 57 complete remissions 57 androgen deprivation 57 thiazolidinedione 57 Cutaneous T 57 Telintra 57 trans retinoic acid ATRA 57 liposomal formulation 57 Engerix B 57 Leukine 57 isoniazid 57 Adefovir 57 IMGN# 57 azoles 57 VICTRELIS 57 Gliadel Wafer 57 ATACAND 57 chemotherapeutic drug 57 TELINTRA 57 Neulasta R 57 Vandetanib 57 Caelyx 57 NeoRecormon 57 relapsed multiple myeloma 57 gemcitabine Gemzar ® 57 Fluorouracil 57 Epratuzumab 57 bosutinib 57 #mg/m# [002] 57 microtubule inhibitor 57 Femara letrozole 57 tanespimycin 57 inhibitor RG# 57 Roche Xeloda 57 levetiracetam 57 nucleotide analogue 57 tricyclic antidepressants 57 olmesartan 57 IFN alfa 57 Neupogen ® 57 Metastatic Colorectal Cancer 57 adjuvant therapy